As in HCC cells, the mechanism of resistance to TRAIL-induced apoptosis is primarily the activation of the NF-κB pathway through both the upregulation of apoptotic inhibitors such as cFLIPL and the upregulation of anti-apoptotic molecules [18–20]. The gene discussed is CFLAR; the disease is hepatocellular carcinoma.